<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02459613</url>
  </required_header>
  <id_info>
    <org_study_id>C13-38</org_study_id>
    <nct_id>NCT02459613</nct_id>
  </id_info>
  <brief_title>Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis</brief_title>
  <acronym>AnnIE</acronym>
  <official_title>Evaluation de la rhAnnexine V-128 radiomarquée Dans le Diagnostic de l'Endocardite Infectieuse, du Thrombus Atrial et de Leurs Complications Emboliques associées</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Advanced Accelerator Applications</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraluminal thrombi adherent to cardiac valves or atria share a common pathophysiology
      involving the aggregation of activated platelets with phosphatidylserine (PS) expression on
      the outer layer of the thrombus. They also share common complications, i.e. damages to the
      underlying myocardium and embolic risk related to thrombus fragmentation. The diagnostic
      work-up, currently relying on morphologic imaging alone (mainly echography), lacks
      sensitivity and does not allow to differentiate between active (renewal and growth activity)
      and quiescent (scarred) thrombus. It is therefore highly desirable to develop a new approach
      able to non-invasively provide insight on the biological activity of thrombi and to detect
      embolic events in a single exam.

      Annexin V is a 36 kDa endogenous glycoprotein which binds PS with nanomolar affinity.
      Radiolabeled Annexin V has been shown to provide molecular imaging of PS expressed by
      apoptotic cells or activated platelets. The ability of the imaging agent to bind mural
      thrombus has been established in vivo in a murine model of abdominal aortic aneurysm and ex
      vivo in human. It has been also shown that radiolabeled Annexin V allowed in vivo detection
      of vegetations and secondary pulmonary emboli with high sensitivity in various animal models
      of infective endocarditis.

      A radiolabeling kit of annexin V complying with GMP requirements has been developed
      (rhAnnexine V-128, Advanced Accelerator Applications - Atreus) and is currently available.
      AnniE is a single centre, proof of concept, interventional, open, non-randomized study aiming
      at evaluating the sensitivity of 99mTc-Annexin V-128 in the detection thrombus in comparison
      with reference imaging in patients presenting with either: 1/ infective endocarditis or 2/
      atrial thrombus. The safety of the 99mTc-Annexin V-128 will be assessed in a first phase (10
      first patients enrolled). Data in relation with safety of the imaging agent will be reviewed
      by an independent Data and Safety Monitoring Board (DSMB); in case of positive answer, the
      study will continue with a second phase. The data gathered in all patients (n=120) will be
      used to determine outcome measures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic sensitivity in infective endocarditis and atrial thrombus</measure>
    <time_frame>up to 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic value (sensitivity and specificity) in infective endocarditis</measure>
    <time_frame>up to 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic sensitivity in atrial thrombus</measure>
    <time_frame>up to 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Endocarditis</condition>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>Imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>99mTc Annexin V-128 SPECT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>99mTc-Annexin V-128 SPECT</intervention_name>
    <arm_group_label>Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable clinical status

          -  signed informed consent

          -  contraception in women of childhood potential

               -  Endocarditis group:

          -  definite ou possible endocarditis (modified Duke criteria)

               -  Atrial thrombosis group:

          -  presence of atrial thrombosis evidenced by transesophageal echocardiography

        Exclusion Criteria:

          -  pregnant or lactating women

          -  contra-indication to both MRI and CT

               -  Endocarditis group:

          -  history of cardiac surgery in relation with the current episode

          -  (effective) antibiotic regimen for more than 15 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Le Guludec, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francois Rouzet, MD, PhD</last_name>
    <phone>+33140256411</phone>
    <email>francois.rouzet@bch.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bichat Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Benali K, Louedec L, Azzouna RB, Merceron O, Nassar P, Al Shoukr F, Petiet A, Barbato D, Michel JB, Sarda-Mantel L, Le Guludec D, Rouzet F. Preclinical validation of 99mTc-annexin A5-128 in experimental autoimmune myocarditis and infective endocarditis: comparison with 99mTc-HYNIC-annexin A5. Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00049.</citation>
    <PMID>25431156</PMID>
  </reference>
  <reference>
    <citation>Rouzet F, Dominguez Hernandez M, Hervatin F, Sarda-Mantel L, Lefort A, Duval X, Louedec L, Fantin B, Le Guludec D, Michel JB. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis. Circulation. 2008 Feb 12;117(6):781-9. doi: 10.1161/CIRCULATIONAHA.107.718114. Epub 2008 Jan 28.</citation>
    <PMID>18227388</PMID>
  </reference>
  <reference>
    <citation>Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy JP, Wolff M, Leport C; IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010 Apr 20;152(8):497-504, W175. doi: 10.7326/0003-4819-152-8-201004200-00006.</citation>
    <PMID>20404380</PMID>
  </reference>
  <reference>
    <citation>Sarda-Mantel L, Coutard M, Rouzet F, Raguin O, Vrigneaud JM, Hervatin F, Martet G, Touat Z, Merlet P, Le Guludec D, Michel JB. 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2153-9. Epub 2006 Jul 20.</citation>
    <PMID>16857952</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2015</study_first_submitted>
  <study_first_submitted_qc>June 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>July 13, 2016</last_update_submitted>
  <last_update_submitted_qc>July 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radionuclide imaging</keyword>
  <keyword>Annexin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Endocarditis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Annexin A5</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

